Yongxia Zhu
Guangxi University(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer-related gene regulation, RNA modifications and cancer, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer(2016)715 cited
- → The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model(2014)131 cited
- → Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model(2015)116 cited
- → Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2(2021)115 cited
- → Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis(2017)89 cited
- → Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort study(2012)79 cited
- → Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma(2016)71 cited
- → Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer(2016)65 cited
- → Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion(2016)59 cited
- → Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance(2023)56 cited